(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
[CAS# 1420478-88-1]

Identification

• Classification: Organic raw materials >> Heterocyclic compound >> Pyrroles
• Name: (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
• Synonyms: benzyl (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
• Molecular Formula: C₁₈H₁₈BrN₅O₂
• Molecular Weight: 416.27
• CAS Registry Number: 1420478-88-1
• EC Number: 817-665-5
• SMILES: C1C[C@H](N(C1)C(=O)OCC2=CC=CC=C2)C3=NC(=C4N3C=CN=C4N)Br

Properties

• Solubility: Insoluble (5.0E^-3 g/L) (25 ºC), Calc.^*
• Density: 1.64±0.1 g/cm³ (20 ºC 760 Torr), Calc.^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)

Safety Data

• Hazard Symbols: GHS07 Warning
• Hazard Statements: H302-H315-H319-H335
• Precautionary Statements: P261-P305+P351+P338

Discovory and Applicatios

(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate is an interesting compound that has attracted much attention in the field of medicinal chemistry and drug development. The discovery of (S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate represents a significant advance in the design of bioactive molecules. Its structural feature is a pyrrolidine ring attached to a benzyl ester group with a complex imidazo[1,5-a]pyrazine moiety bearing amino and bromine substituents. This special arrangement can enhance the interaction with biological targets and has become a valuable research topic.

In medicinal chemistry, (S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate is being explored for potential therapeutic applications. The imidazo[1,5-a]pyrazine structure is known to interact with various biological receptors and enzymes, thereby affecting cellular processes and disease mechanisms. Research is focused on evaluating its efficacy as a potential drug candidate for diseases such as cancer, where targeting specific molecular pathways is critical.

Ongoing research is dedicated to understanding the pharmacokinetics and pharmacodynamics of this compound. Scientists are investigating its mechanism of action, stability, and bioavailability to determine its suitability as a therapeutic agent. Preliminary studies show promise, and further research may reveal its potential in clinical settings.

(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate embodies an innovative approach to drug design and development. Its unique chemical structure and potential therapeutic benefits make it an exciting compound for future investigation, especially in developing new treatments for complex diseases. As research progresses, this compound may play a key role in advancing medical science and improving patient outcomes.